Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala
Official title: Uppsala Self-Screening of Cardiovascular Health: A Randomized Controlled Trial of Home-Based Multimodal Cardiovascular Screening Versus Usual Care in Middle-Aged and Older Adults
Run by Uppsala University · NCT07614659 · Data updated 2026-11-12
This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 75 Years |
| Sex | All |
| Enrollment | 45000 (estimated) |
| Sponsor | Uppsala University Academic / other |
| Locations | 1 site (Uppsala) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2037 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT07614659 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Residents of Region Uppsala aged 50, 55, 60, 65, 70, or 75 who can provide informed consent.
✕Probably not a fit
Individuals unable to use home testing devices or who do not have actionable cardiovascular risks may see no personal benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
U-SCREEN is a pragmatic randomized trial in Region Uppsala that assigns residents aged 50, 55, 60, 65, 70 or 75 to either a home-based, multimodal screening package or to usual care. The screening arm includes a home blood pressure monitor, a dried blood spot kit for ApoB, HbA1c and creatinine, and a digital questionnaire to assess risk. Primary goals are to see if this approach identifies more actionable risk factors, influences preventive treatment, and impacts cardiovascular events, healthcare use, costs, and patient-reported outcomes. The study uses register-based follow-up with a 1:1 randomization and targets up to 10,000 participants recruited between 2024 and 2027. It is led by Johan Sundström with Region Uppsala Public Health and Care and Uppsala University Hospital involved in the conduct.
Why it matters
Potential benefit: If successful, participants could receive earlier detection of treatable cardiovascular risks and faster initiation of preventive care.
How similar studies have gone: Digital and home-based screening approaches have shown potential in identifying risk factors, but large-scale population-level effectiveness remains to be proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Resident in Region Uppsala, Sweden * Turning 50, 55, 60, 65, 70 or 75 years during recruitment period * Able to provide informed consent Exclusion Criteria: * Inability to provide informed consent * Protected identity
Where it's running
-
Uppsala University Hospital
Uppsala, Sweden Recruiting
Study contacts
- Principal investigator: Johan Sundström, MD, PhD — Uppsala University
- Study coordinator: Johan Sundström, MD, PhD
- Email: johan.sundstrom@uu.se
- Phone: +46 70 422 52 20
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Research on health inequality and genetic disparity in cardiovascular diseases
This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.
-
Taining Golden Lake comprehensive chronic disease management program
This project will build a large cohort of adults in Taining County to collect health data and try to create a county-level chronic disease management model for people with hypertension, diabetes, dyslipidemia, and other long-term conditions.
-
Streamlined renal denervation with Spyral for uncontrolled high blood pressure
This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.
-
Gemini multi-organ denervation for uncontrolled high blood pressure
The Gemini System is being tested to see if multi-organ denervation is safe and can lower blood pressure in adults with uncontrolled hypertension, with or without high cardiovascular risk.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Examining retinal blood vessels in patients with common internal diseases using advanced imaging
This study is trying to see how conditions like high blood pressure, diabetes, and high cholesterol affect the blood vessels in the eyes over five years using advanced imaging technology.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.